Cytori Therapeutics (CYTX) Slipping Towards A Bearish Zone Below $5.31
By Mark Moneymaster
March 12, 2010 1:48 PM
March 12, 2010 1:48 PM
Symbols: CYTX
Cytori Therapeutics (NASDAQ: CYTX), a maker of products used in adult stem cell harvesting and research, said Friday its Q4 loss moved up as its sales and marketing and some other expenses grew in the Q4. Cytori Therapeutics (CYTX), a small-cap company, lost $9.5 million in Q4.
The small-cap stock Cytori Therapeutics (CYTX) has already shed 21.25% by early afternoon trading on Friday, following the poor quarterly performance. Cytori Therapeutics (CYTX) , which has slippe on very strong volumes today, will start showing bearish trend, once it breaches below its 200 day MA of $5.31.
(c) 2011 Benzinga.com. All rights reserved. This material may not be published in its entirety or redistributed without the approval of Benzinga.
We're Loving
